Decreased expression of CD64/FcγRI on peripheral blood monocytes has been reported in RA patients who were treated with methotrexate or TNF inhibitors, especially those who were good responders [26, 27], suggesting a relationship between CD64/FcγRI expression on monocytes and RA disease activity. This evidence concerns the gene FCGR1A and rheumatoid arthritis.